Alimentiv Announces Pierre Gaudreault as New Chief Executive Officer
London, Ontario, Canada, January 8, 2024 – Alimentiv Inc. (“Alimentiv”) is pleased to announce the appointment of Pierre Gaudreault as its Chief Executive Officer, effective…
London, Ontario, Canada, January 8, 2024 – Alimentiv Inc. (“Alimentiv”) is pleased to announce the appointment of Pierre Gaudreault as its Chief Executive Officer, effective…
We recently published a summary article on the size of the contract research market for the period of 2023 to 2028. We collated data from multiple sources….
LONDON, ON, November 8, 2023 – Alimentiv Inc., AcelaBio Inc., and PharmaNest Inc. are pleased to announce their collaborative effort aimed at revolutionizing precision medicine…
London, Ontario, Canada, October 13, 2023, Alimentiv Inc. (“Alimentiv”), a leading Contract Research Organization focused on GI-related therapeutics, is pleased to announce the addition of…
Due to Contract Research Organizations’ (CROs) significant impact on drug development and healthcare advancements, understanding the size and future growth of the CRO Market is…
London, Canada and Vancouver, Canada – Alimentiv, a global contract research organization (CRO) providing clinical trials, central image management, precision medicine, and real-world evidence services…
Join us at DDW to explore Alimentiv’s groundbreaking research.
When: May 3–6, 2025 in San Diego, CA
Booth #4549